Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3977405 | Brachytherapy | 2011 | 4 Pages |
Abstract
Excellent local control, eye preservation rates, and survival outcomes following 125I episcleral plaque application for CM can be optimized by having an experienced ophthalmologist place the plaques. Additionally, hepatic metastasis can occur more than 5 years postimplant regardless of local control; therefore, longer systemic staging should be considered.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Brian Karlovits, Mark G. Trombetta, Thierry Verstraeten, Mark Johnson, Michael Wong, Stephen Karlovits,